DEM Biopharma is a pre-IND stage biopharmaceutical company dedicated to discovering novel therapeutic targets for solid tumors. Our innovative platform enables us to identify unique strategies to attack tumor cells and the tumor microenvironment (TME).
We have an Experienced Leadership and Operating team, World-Class Scientific Founders and Advisors, and outstanding Investor Syndicate.
